Education
About Us
Working with TipRanks
Follow Us
Celularity (CELU)
NASDAQ:CELU
CELU Stock Chart & Stats
$1.25
-$0.06(-2.69%)
At close: 4:00 PM EST
$1.25
-$0.06(-2.69%)
Day’s Range― - ―
52-Week Range$1.00 - $4.35
Previous Close$2.13
Volume115.00K
Average Volume (3M)206.82K
Market Cap
$36.83M
Enterprise Value$116.37M
Total Cash (Recent Filing)$120.00K
Total Debt (Recent Filing)$66.76M
Price to Earnings (P/E)―
Beta3.41
Next Earnings
Mar 26, 2026EPS Estimate
-1.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.02
Shares Outstanding28,328,880
10 Day Avg. Volume277,262
30 Day Avg. Volume206,824
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)5.15
Price to Sales (P/S)0.84
P/FCF Ratio-6.94
Enterprise Value/Market Cap3.16
Enterprise Value/Revenue2.87
Enterprise Value/Gross Profit5.19
Enterprise Value/Ebitda-1.83
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial RestructuringCelularity successfully eliminated its long-term debt through strategic financial restructuring.
Market StandingCelularity regained compliance with NASDAQ listing rules, improving its market standing.
Production CapacityCelularity has industry-leading production capacity, providing a competitive advantage in a high-cost sector.
Bears Say
Celularity News
CELU FAQ
What was Celularity’s price range in the past 12 months?
Celularity lowest stock price was $1.00 and its highest was $4.35 in the past 12 months.
What is Celularity’s market cap?
Celularity’s market cap is $36.83M.
When is Celularity’s upcoming earnings report date?
Celularity’s upcoming earnings report date is Mar 26, 2026 which is in 96 days.
How were Celularity’s earnings last quarter?
Celularity released its earnings results on Aug 18, 2025. The company reported -$1.02 earnings per share for the quarter, missing the consensus estimate of -$0.75 by -$0.27.
Is Celularity overvalued?
According to Wall Street analysts Celularity’s price is currently Overvalued.
Does Celularity pay dividends?
Celularity does not currently pay dividends.
What is Celularity’s EPS estimate?
Celularity’s EPS estimate is -1.5.
How many shares outstanding does Celularity have?
Celularity has 28,328,880 shares outstanding.
What happened to Celularity’s price movement after its last earnings report?
Celularity reported an EPS of -$1.02 in its last earnings report, missing expectations of -$0.75. Following the earnings report the stock price went up 19.253%.
Which hedge fund is a major shareholder of Celularity?
Currently, no hedge funds are holding shares in CELU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Celularity Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.31%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-11.23%
Trailing 12-Months
Company Description
Celularity
Celularity Inc. is a biotechnology company focused on developing innovative cell-based therapies for the treatment of cancer, degenerative diseases, and other serious conditions. The company leverages its proprietary platform that utilizes placental-derived cells, particularly those from the human placenta, to create advanced therapeutic products. Celularity operates primarily within the sectors of regenerative medicine and immunotherapy, aiming to harness the unique properties of these cells to improve patient outcomes.
Technical Analysis
Lantern Pharma
―
Generation Bio
―
Repare Therapeutics
―
Shattuck Labs
―
FibroBiologics, Inc.
―
Ownership Overview
26.53% Insiders
2.53% Mutual Funds
3.69% Other Institutional Investors
65.06% Public Companies and
Individual Investors